4-Factor prothrombin complex concentrates and factor VIII inhibitor bypass activity use in cardiac surgery
Among cardiac surgery patients, there was no difference in thromboembolic events between patients who received 4F-PCC or FEIBA when used as an adjunct to blood product administration.
Authors
- Louanne M. Carabini (ORCID: https://orcid.org/0000-0002-4361-9896)
- Ashley N. Budd
- Robert J. McCarthy (ORCID: https://orcid.org/0000-0002-0966-5311)
- Suraj D. Parulkar
Institutions
- Rush University Medical Center (US)
Publication Details
- Journal
- Blood Coagulation & Fibrinolysis
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1097/mbc.0000000000001335
- Citations
- 1
- Primary Topic
- Blood transfusion and management
- Type
- article
- Field-Weighted Citation Impact
- 0.22